Potent and selective non-cysteine-containing inhibitors of protein farnesyltransferase

被引:45
作者
Augeri, DJ
O'Connor, SJ
Janowick, D
Szczepankiewicz, B
Sullivan, G
Larsen, J
Kalvin, D
Cohen, J
Devine, E
Zhang, HC
Cherian, S
Saeed, B
Ng, SC
Rosenberg, S
机构
[1] Abbott Labs, Dept Canc Res, Abbott Pk, IL 60064 USA
[2] Abbott Labs, Dept Combinatorial Chem, Abbott Pk, IL 60064 USA
关键词
D O I
10.1021/jm980298s
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Potent and selective non-thiol-containing inhibitors of protein farnesyltransferase are described. FTI-276 (1) was transformed into pyridyl ether analogue 19. The potency of pyridyl ether 19 was improved by modification of the biphenyl core to that of an o-tolyl substituted biphenyl core to give 29. In addition to 0.4 nM in vitro potency, 29 displayed 350 nM potency in whole cells as the parent carboxylic acid. The o-tolyl biphenyl core dramatically and unexpectedly enhanced the potency of other compounds as exemplified by 46, 47, 48, and 49.
引用
收藏
页码:4288 / 4300
页数:13
相关论文
共 31 条
  • [1] RAS GENES
    BARBACID, M
    [J]. ANNUAL REVIEW OF BIOCHEMISTRY, 1987, 56 : 779 - 827
  • [2] BOS JL, 1989, CANCER RES, V49, P4682
  • [3] Novel conformationally extended naphthalene-based inhibitors of farnesyltransferase
    Burns, CJ
    Guitton, JD
    Baudoin, B
    Lelievre, Y
    Duchesne, M
    Parker, F
    Fromage, N
    Commercon, A
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (12) : 1763 - 1767
  • [4] CASEY PJ, 1989, P NATL ACAD SCI USA, V86, P8223
  • [5] Farnesyltransferase inhibitors and cancer treatment: targeting simply Ras?
    Cox, AD
    Der, CJ
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 1997, 1333 (01): : F51 - F71
  • [6] Cox Adrienne D., 1992, Current Opinion in Cell Biology, V4, P1008, DOI 10.1016/0955-0674(92)90133-W
  • [7] PSEUDODIPEPTIDE INHIBITORS OF PROTEIN FARNESYLTRANSFERASE
    DESOLMS, SJ
    DEANA, AA
    GIULIANI, EA
    GRAHAM, SL
    KOHL, NE
    MOSSER, SD
    OLIFF, AI
    POMPLIANO, DL
    RANDS, E
    SCHOLZ, TH
    WIGGINS, JM
    GIBBS, JB
    SMITH, RL
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (20) : 3967 - 3971
  • [8] The potential of farnesyltransferase inhibitors as cancer chemotherapeutics
    Gibbs, JB
    Oliff, A
    [J]. ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1997, 37 : 143 - 166
  • [9] FARNESYLTRANSFERASE INHIBITORS - RAS RESEARCH YIELDS A POTENTIAL CANCER THERAPEUTIC
    GIBBS, JB
    OLIFF, A
    KOHL, NE
    [J]. CELL, 1994, 77 (02) : 175 - 178
  • [10] PSEUDOPEPTIDE INHIBITORS OF RAS FARNESYL-PROTEIN TRANSFERASE
    GRAHAM, SL
    DESOLMS, SJ
    GIULIANI, EA
    KOHL, NE
    MOSSER, SD
    OLIFF, AI
    POMPLIANO, DL
    RANDS, E
    BRESLIN, MJ
    DEANA, AA
    GARSKY, VM
    SCHOLZ, TH
    GIBBS, JB
    SMITH, RL
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1994, 37 (06) : 725 - 732